Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹133 Cr
Revenue (TTM)
₹0 Cr
Net Profit (TTM)
₹0 Cr
ROE
51.7 %
ROCE
51.7 %
P/E Ratio
--
P/B Ratio
16
Industry P/E
--
EV/EBITDA
-561.1
Div. Yield
0 %
Debt to Equity
0
Book Value
₹6.4
EPS
₹-0.2
Face value
10
Shares outstanding
13,000,000
CFO
₹-6.22 Cr
EBITDA
₹-4.46 Cr
Net Profit
₹-0.51 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Genesis IBRC India
| 20.0 | 48.5 | 14.7 | 458.1 | -- | -- | -- |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
|
Company
|
2025
|
2020
|
|---|---|---|
|
Genesis IBRC India
| 386.2 | -3.7 |
|
BSE Small Cap
| -6.6 | 32.1 |
|
BSE Healthcare
| -3.3 | 61.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Genesis IBRC India
|
102.4 | 133.1 | 0.0 | -0.2 | -- | -2.8 | -- | 16.0 |
| 635.5 | 35,564.9 | 1,844.6 | 451.3 | -- | 21 | 78.8 | 12.5 | |
| 636.2 | 32,981.0 | 4,461.2 | 397.5 | 13.4 | 9.1 | 100.9 | 7.2 | |
| 423.5 | 13,410.5 | 1,976.2 | 160.7 | 14.1 | 6.7 | 106.4 | 6.8 | |
| 1,325.4 | 22,213.6 | 2,662.8 | 533.1 | 22.9 | 24.1 | 42 | 8.7 | |
| 63.0 | 125.5 | 50.3 | -2.1 | -3.3 | -6.3 | -- | 1.9 | |
| 657.6 | 26,355.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 87.6 | 11.3 | |
| 1,823.8 | 9,460.1 | 1,566.5 | 169.5 | 14.8 | 12.7 | 56.2 | 6.4 | |
| 1,103.8 | 11,233.0 | 1,613.3 | 259.9 | 23.0 | 17.3 | 43.6 | 7.1 | |
| 418.8 | 1,870.5 | 392.5 | 74.7 | 24.2 | 19.1 | 25 | 4.3 |
No Review & Analysis are available.
Genesis IBRC India Limited engages in the manufacture and marketing of pro-biotic products for aquaculture, agriculture, poultry, and animal husbandry markets in India. The company's products include GENPRO-WAT water and soil probiotic, Pro-VIBSOL... vibro controller, AMMONO-GEN ammonia and nitrites reducing probiotic, GENLACT gut and intestinal probiotic, GROWFAST-GEN single cell protein, and GEN-POND CLEAN fast decomposer. It also provides formulation research and development services for aquaculture bio formulations and feed supplements, poultry bio formulations, and veterinary bio formulations, as well as agriculture bio formulations and plant, and seaweed extracts; need based product design services; mobile and land lab services; and consultation services in the aquaculture, agriculture, poultry, and veterinary fields. The company was formerly known as SSK Lifestyles Limited and changed its name to Genesis IBRC India Limited in January 2018. Genesis IBRC India Limited was incorporated in 1992 and is based in Denduluru, India. Read more
Incorporated
1992
Chairman
--
Managing Director
--
Headquarters
Eluru, Andhra Pradesh
Website
Looking for more details about Genesis IBRC India Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Genesis IBRC India Ltd is ₹102.35 (BSE) as of 19-Mar-2026 IST. Genesis IBRC India Ltd has given a return of 458.07% in the last 1 years.
Since, TTM earnings of Genesis IBRC India Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
6.80
|
2.79
|
|
2024
|
0.00
|
3.38
|
|
2023
|
0.00
|
1.57
|
|
2022
|
0.00
|
1.35
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Genesis IBRC India Ltd are Rs 184.90 and Rs 18.34 as of 19-Mar-2026.
Genesis IBRC India Ltd has a market capitalisation of ₹ 133 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Genesis IBRC India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.05
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.